The Impact of COVID-19 Pandemic on the Treatment of Patients with Head and Neck Cancer at a Reference Hospital
DOI:
https://doi.org/10.32635/2176-9745.RBC.2026v72n3.5577Keywords:
Pandemic, COVID-19, Head and Neck NeoplasmsAbstract
Introduction: The COVID-19 pandemic caused by SARS-CoV-2 virus had high infection ratios and mortality due to its fast spread. Therefore, the reinforcement of the health system to treat the patients restricted the operation of several specialties and many health units postponed elective activities, for example, the care to oncological patients, who eventually did not receive the ideal treatment. Objective: To evaluate the impact of COVID-19 pandemic on the treatment of patients with head and neck cancer in a high complexity unit at a reference hospital. Method: Data from patients with head and neck cancer were collected between 2018 and 2021. The number of assisted patients, mean time between head and neck cancer diagnosis and beginning of radiotherapy, as well as the number of surgeries and chemo and radiotherapy sessions, tumoral staging and medical record of oral complications of antineoplastic treatment have been analyzed. Results: There was a significant increase of oral lesions in medical charts during the pandemic. In 2020 there was a higher prevalence of oral and lip cancer and IVA stage tumors. Conclusion: The pandemic did not negatively impact the care to patients with head and neck cancer, but interfered on the elective treatment.
Downloads
References
Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmunity. 2020;109:102433. doi: https://doi.org/10.1016/j.jaut.2020.102433 DOI: https://doi.org/10.1016/j.jaut.2020.102433
Sanyaolu A, Okorie C, Marinkovic A, et al. Comorbidity and its Impact on Patients with COVID-19. SN Compr Clin Med. 2020;2(8):1069-76. doi: https://doi.org/10.1007/s42399-020-00363-4 DOI: https://doi.org/10.1007/s42399-020-00363-4
Chaves ALF, Castro AF, Marta GN, et al. Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic. Oral Oncol. 2020;107:104734. doi: https://doi.org/10.1016/j.oraloncology.2020.104734 DOI: https://doi.org/10.1016/j.oraloncology.2020.104734
Chow LQM. Head and neck cancer. N Engl J Med. 2020;382(1):60-72. doi: https://doi.org/10.1056/nejmra1715715 DOI: https://doi.org/10.1056/NEJMra1715715
Bozec A, Culié D, Poissonnet G, et al. Current role of primary surgical treatment in patients with head and neck squamous cell carcinoma. Curr Opin Oncol. 2019;31(3):138-45. doi: https://doi.org/10.1097/cco.0000000000000531 DOI: https://doi.org/10.1097/CCO.0000000000000531
Blanchard P, Michiels S, Fayette J, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 107 randomized trials and 19 805 patients. Lancet Oncol. 2015;16(2):187-99.
Instituto Nacional de Câncer. Intervalo de tempo entre o diagnóstico e o início do tratamento oncológico dos casos de câncer de lábio e cavidade oral. Rio de Janeiro: INCA; 2020.
Lalla RV, Treister N, Sollecito T, et al. OraRad Study Group. Oral complications at 6 months after radiation therapy for head and neck cancer. Oral Dis. 2017;23(8):1134-43. doi: https://doi.org/10.1111/odi.12710 DOI: https://doi.org/10.1111/odi.12710
Conselho Federal de Odontologia (BR). Recomendações para atendimentos odontológicos em tempos de COVID-19 [Internet]. Brasília, DF: CFO; 2020 [acesso 2023 maio 4]. Disponível em: URL: https://website.cfo.org.br/wp-content/uploads/2020/03/Material-Coronavi%CC%81rus-Dentistas-CFO.pdf
Zhang W, Jiang X. Measures and suggestions for the prevention and control of the novel coronavirus in dental institutions. Front Oral Maxillofac Med 2020;2:4. doi: https://doi.org/10.21037/fomm.2020.02.01 DOI: https://doi.org/10.21037/fomm.2020.02.01
Matos LL, Forster CHQ, Marta GN, et al. The hidden curve behind COVID-19 outbreak: the impact of delay in treatment initiation in cancer patients and how to mitigate the additional risk of dying-the head and neck cancer model. Cancer Causes Control. 2021;32(5):459-71. doi: https://doi.org/10.1007/s10552-021-01411-7 DOI: https://doi.org/10.1007/s10552-021-01411-7
Rygalski CJ, Zhao S, Eskander A, et al. Time to surgery and survival in head and neck cancer. Ann Surg Oncol. 2021;28(2):877-85. doi: https://doi.org/10.1245/s10434-020-09326-4 DOI: https://doi.org/10.1245/s10434-020-09333-5
Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93-9. DOI: https://doi.org/10.3322/caac.21388
Conselho Nacional de Saúde (BR). Resolução nº 466 de 12 de dezembro de 2012. Aprova diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos. Diário Oficial da União, Brasília, DF. 2013 jun 13; Edição 112; Seção 1:59.
Schoonbeek RC, Jel DVC, van Dijk BAC, et al. Fewer head and neck cancer diagnoses and faster treatment initiation during COVID-19 in 2020: a nationwide population-based analysis. Radiother Oncol. 2022;167:42-8. DOI: https://doi.org/10.1016/j.radonc.2021.12.005
Tevetoğlu F, Kara S, Aliyeva C, et al. Delayed presentation of head and neck cancer patients during COVID-19 pandemic. Eur Arch Otorhinolaryngol. 2021;278(12):5081-5. doi: https://doi.org/10.1007/s00405-021-06728-2 DOI: https://doi.org/10.1007/s00405-021-06728-2
Kiong KL, Diaz EM, Gross ND, et al. The impact of COVID‐19 on head and neck cancer diagnosis and disease extent. Head Neck. 2021;43(6):1890-7. doi: https://doi.org/10.1002/hed.26665 DOI: https://doi.org/10.1002/hed.26665
Silva FA, Roussenq SC, Tavares MGS, et al. Perfil epidemiológico dos pacientes com câncer de cabeça e pescoço em um centro oncológico no sul do Brasil. Rev Bras Cancerol. 2020;66(1):e-08455. doi: https://doi.org/10.32635/2176-9745.RBC.2020v66n1.455 DOI: https://doi.org/10.32635/2176-9745.RBC.2020v66n1.455
Instituto Nacional de Câncer. Diagnóstico Precoce do Câncer De Boca. Rio de Janeiro: INCA;2022.
Ralli M, Candelori F, Cambria F, et al. Impact of COVID-19 pandemic on otolaryngology, ophthalmology and dental clinical activity and future perspectives. Eur Rev Med Pharmacol Sci. 2020;24(18):9705-11.
American Society for Radiation Oncology. Results of a national physician survey by the American Society for Radiation Oncology (ASTRO) [Internet]. Arlington: ASTRO; 2021 [acesso 2025 dez 17]. Disponível em: https://www.astro.org/ASTRO/media/ASTRO/News%20and%20Publications/PDFs/ASTRO_COVID19Survey_2021.pdf
Araujo SEA, Leal A, Centrone AFY, et al. Impacto da COVID-19 sobre o atendimento de pacientes oncológicos: experiência de um centro oncológico localizado em um epicentro Latino-Americano da pandemia. Einstein (São Paulo). 2020;19:1-8. doi: https://doi.org/10.31744/einstein_journal/2021AO6282 DOI: https://doi.org/10.31744/einstein_journal/2021AO6282
Chone CT. Increased mortality from head and neck cancer due to SARS-CoV-2 pandemic. Braz J Otorhinolaryngol. 2021;87(1):1-2. doi: https://doi.org/10.1016/j.bjorl.2020.11.001 DOI: https://doi.org/10.1016/j.bjorl.2020.11.001
Ralli M, Colizza A, Cambria F, et al. Effects of COVID-19 pandemic on head and neck oncology activity: the experience of our University Hospital. Eur Rev Med Pharmacol Sci. 2021;25(23):7268-71. doi: https://doi.org/10.26355/eurrev_202112_27419
Favaro E, Fernandes DR, Vieira LG, et al. Complicações pós-operatórias em pacientes adultos submetidos a cirurgias com infecção confirmada por SARS-CoV-2: revisão integrativa. Rev Latino-Am Enfermagem. 2021;29:e3496. doi: https://doi.org/10.1590/1518-8345.5346.3496 DOI: https://doi.org/10.1590/1518-8345.5346.3496
Ürün Y, Hussain SA, Bakouny Z, et al. Survey of the impact of COVID-19 on oncologists' decision making in cancer. JCO Glob Oncol. 2020;6:1248-57. doi: https://doi.org/10.1200/go.20.00300 DOI: https://doi.org/10.1200/GO.20.00300
Galbiatti AL, Padovani-Junior JA, Maníglia JV, et al. Head and neck cancer: causes, prevention and treatment. Braz J Otorhinolaryngol. 2013;79(2):239-47. doi: https://doi.org/10.5935/1808-8694.20130041 DOI: https://doi.org/10.5935/1808-8694.20130041
Zhang L, Zhu F, Xie L, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020;31(7):894-901. DOI: https://doi.org/10.1016/j.annonc.2020.03.296
Published
How to Cite
Issue
Section
License
Os direitos morais e intelectuais dos artigos pertencem aos respectivos autores, que concedem à RBC o direito de publicação.
This work is licensed under a Creative Commons Attribution 4.0 International License.
